PavmedPAVM

13F holders, Q3 2024 (September 30)
22holders −4
1new positions
5sold out
$1.23avg. 13F price*

At the end of Q3 2024, 22 institutions reported holding Pavmed Inc. (PAVM) in their 13F filings, down 4 from Q2 2024. 1 opened new positions and 5 sold out. The largest holders were First Manhattan Co. Llc. ($738K), Vanguard Group Inc. ($346K) and Geode Capital Management, LLC ($101K).

Company
Pavmed Inc.
CUSIP
70387R403
Latest filing quarter
Q4 2025

History

Number of 13F holders

010203040 Q1 2024: 24Q1 2024Q2 2024: 26Q2 2024Q3 2024: 22Q3 2024Q4 2024: 26Q4 2024Q1 2025: 31Q1 2025Q2 2025: 31Q2 2025Q3 2025: 35Q3 2025Q4 2025: 28Q4 2025

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions1$26K
Exits5$103K

All 13F filers, Q2 2024 → Q3 2024: 130,868 shares bought and 105,818 shares sold, net +25,050 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 22 holders

First Manhattan Co. Llc. 0.00% Add +20.0% 600,000 $738K
Vanguard Group Inc. 0.00% Reduce -4.9% 281,015 $346K
Geode Capital Management, LLC 0.00% Add +12.0% 82,496 $101K
BlackRock, Inc. 0.00% — 74,912 $92K
Obermeyer Wealth Partners 0.00% New 21,500 $26K
State Street Corp. 0.00% No change 20,854 $26K
Northern Trust Corp. 0.00% No change 11,706 $14K
XML Financial, LLC 0.00% No change 10,067 $12K
Cwm, LLC 0.00% No change 4,672 $6K
Morgan Stanley 0.00% Reduce -4.6% 4,834 $6K
Tower Research Capital LLC (TRC) 0.00% Reduce -61.8% 3,712 $5K
Wells Fargo & Company 0.00% Reduce -28.6% 2,785 $3K
CIBC Private Wealth Group LLC 0.00% No change 836 $1K
Bank of America Corp. 0.00% Add +606.3% 558 $687
Allworth Financial LP 0.00% Add +6.4% 447 $550
Osaic Holdings, Inc. 0.00% No change 116 $142
Parallel Advisors, LLC 0.00% No change 78 $96
M&R Capital Management Inc. 0.00% No change 67 $82
JPMorgan Chase & Co. 0.00% Reduce -46.0% 20 $24
UBS Group AG 0.00% Reduce -99.8% 9 $11
Thompson Investment Management, Inc. 0.00% No change 4 $5
Steward Partners Investment Advisory, LLC 0.00% No change 1 $1

"% of holder's portfolio" is PAVM's weight in each manager's 13F, not the share of Pavmed Inc. the manager owns.